The metabotropic glutamate receptor 7 (mGlu7) is a class C G protein-coupled receptor (GPCR) that modulates 2 excitatory neurotransmitter release at the presynaptic active zone. Although post-translational modification of 3 cellular proteins with ubiquitin is a key molecular mechanism governing protein degradation and function, mGlu7 4 ubiquitination and its functional consequences have not been elucidated yet. Here, we report that Nedd4 ubiquitin 5 E3 ligase and -arrestins regulate ubiquitination of mGlu7 in heterologous cells and neurons. Upon agonist-6 stimulation, -arrestins recruit Nedd4 to mGlu7 and facilitate Nedd4-mediated ubiquitination of mGlu7. Nedd4 and 7 -arrestins regulate constitutive and agonist-induced endocytosis of mGlu7 and are required for mGlu7-dependent 8 MAPK signaling in neurons. In addition, Nedd4-mediated ubiquitination results in the degradation of mGlu7 by 9 both the lysosomal and proteasomal degradation pathways. These findings provide a model in which Nedd4 and -10 arrestin act together as a complex to regulate mGlu7 surface expression and function at the presynaptic terminals. 11 12
Results 1 mGlu7 is ubiquitinated by agonist stimulus or Nedd4 E3 ligase in heterologous cells and 2 neurons 3 To explore if ubiquitination determines mGlu7 trafficking and function, we first tested if mGlu7 could be modified 4 by ubiquitination in heterologous cells. We co-transfected c-myc epitope-tagged mGlu7a in the extracellular N-5
terminal domain (myc-mGlu7) and hemagglutinin epitope-tagged ubiquitin (HA-Ub) in HEK 293T cells. The 6 transfected cell lysates were immunoprecipitated with anti-myc antibody and blotted with anti-HA antibody to detect 7 the ubiquitin-conjugated mGlu7. We observed diffuse high-molecular-weight mGlu7 immunoreactivities in the lane 8 co-transfected with mGlu7 and ubiquitin, but not in the control lane transfected with either mGlu7 or ubiquitin, 9
indicative of ubiquitinated mGlu7 signals (Figure 1A) . We found that the ubiquitinated mGlu7 bands are present 10 mainly in dimeric and multimeric forms with apparent molecular weights larger than 200 kDa, whereas the 11 monomeric form of mGlu7 (~100 kDa) is barely ubiquitinated (Figure 1A) . 12 To explore if agonist-induced activation of mGlu7 induces receptor ubiquitination, we treated HEK 293T cells 13 with 1 mM L-glutamate (L-Glu) on following co-expression of myc-mGlu7 and HA-Ub. We were able to observe an 14 approximately 2-fold increase in mGlu7 ubiquitination within 10 min of agonist stimulation, which was sustained up 15 to 60 min. Total mGlu7 level was reduced after 30 min most likely due to receptor degradation (Figure 1B) . Next, 16 we examined the endogenous ubiquitination of mGlu7 in cultured hippocampal neurons following Group III mGlu 17 receptors agonist L-AP4 (400 M) treatment for 5 min. The ubiquitinated mGlu7 was pulled down using an anti-18 ubiquitin antibody (clone FK2) and blotted with mGlu7 antibody. We found that L-AP4 treatment increases 19 endogenous mGlu7 ubiquitination in neurons by approximately 2-fold ( Figure 1C) . To distinguish whether surface-20 expressed or intracellular mGlu7 undergoes ubiquitin modification, we devised a two-round purification strategy 21 after cell surface biotinylation and separated the surface versus internal ubiquitinated proteins ( Figure 1D) . 22
Specifically, cultured neurons were incubated with L-AP4 for 5 min and surface proteins were labeled by 23 membrane-impermeable biotin. Cell lysates were then pulled down with streptavidin-agarose beads. The supernatant 24 was considered to be the intracellular fraction, and the surface fraction was obtained from bead-bound proteins. The 25 ubiquitinated proteins were subsequently isolated from the surface or intracellular fraction using FK2 antibodies, 26
respectively. We found that surface-expressed mGlu7 undergoes agonist-induced ubiquitination, whereas 27 intracellular mGlu7 does not (Figure 1D) . This result suggests that mGlu7 ubiquitination occurs in combination 28
with an agonist-induced endocytosis process. 29
As E3 Ub ligase largely determines the substrate specificity of ubiquitination, we searched for the E3 ligases 30 responsible for mGlu7 ubiquitination. We tested a Nedd4 E3 ligase because Nedd4 has been implicated in regulating 31 the turnover and trafficking of many ion channels and GPCRs in neurons (Han et were treated with L-AP4 for 5 min, and cell lysates were immunoprecipitated with anti-mGlu7 antibody and western blotting was 9 carried out with the indicated antibodies. Bar graph represents mean ± SEM (L-AP4, 2.36 ± 0.36; n = 3, *p < 0.05, Student's t-10 test). (H) HA-tagged K48 or K63 Ub was co-transfected with mGlu7 in HEK 293T cells. The cells were treated with MG132 (10 11 μM) and leupeptin (52.5 μM) for 5 h to inhibit the proteasomal and lysosomal degradation of the receptor. The cells were 12 stimulated with L-Glu for 5 min before harvesting. K48-or K63-mediated ubiquitination levels were quantified after 13 normalization to total ubiquitination levels. Bar graph below represents mGlu7 band intensities normalized to Ub-WT (means ±
14
SEM; Ub-K48, 1.01 ± 0.19; Ub-K63, 1.02 ± 0.15; n = 6, n.s. indicates p > 0.05, one-way ANOVA).
16
ubiquitination level of mGlu7 ( Figure 1E) . To confirm the essential role of Nedd4 in agonist-induced mGlu7 17 ubiquitination, we knocked down the endogenous expression of Nedd4 using lentivirus-mediated short hairpin RNA 18 (shRNA) in cultured cortical neurons. Nedd4 shRNA was highly effective in knocking down endogenous Nedd4 19 expression 7 days after infection. Notably, agonist L-AP4-induced mGlu7 ubiquitination was markedly reduced by 20
Nedd4 knockdown (Nedd4 KD), indicating that Nedd4 is required for agonist-induced mGlu7 ubiquitination 21 ( Figure 1F) . To examine the interaction of Nedd4 with its substrate mGlu7, endogenous mGlu7 from cultured 22 hippocampal neurons was immunoprecipitated and blotted with anti-Nedd4 antibody. We observed constitutive 23 interaction between endogenous Nedd4 and mGlu7, and their interaction was markedly enhanced after treatment of 24 L-AP4 for 5 min (Figure 1G) . Taken together, these results indicate that Nedd4 is recruited to mGlu7 upon agonist-25 stimulation and plays a role in an E3 ubiquitin ligase for mGlu7 ubiquitination. 26
It is well known that among seven lysine residues of the ubiquitin protein, the formation of K48-or K63-27 linked polyubiquitin chain typically directs protein substrates to the proteasomal degradation or endocytic 28 trafficking, respectively (Alonso and Friedman, 2013; Dores and Trejo, 2012). To identify which types of ubiquitin 29 linkages are preferentially attached to mGlu7, HA-ubiquitin K48 (ubiquitin with only a K48 residue, other lysines 30 mutated to arginines) or HA-K63 (ubiquitin with only a K63 residue, other lysines mutated to arginines) expression 31 plasmids were co-transfected with mGlu7. Although K63 ubiquitin was more efficiently conjugated to mGlu7 than 32 K48 ubiquitin, there was no significant difference between K48-or K63-linked mGlu7 ubiquitination when their 33 mGlu7 ubiquitination levels were normalized by the total expression levels of ubiquitin K48 or K63, respectively 34 ( Figure 1H ). This result implicates that ubiquitination of mGlu7 may regulate receptor endocytosis as well as 35 degradation. 36 37 mGlu7 is ubiquitinated on the lysine residues of the C-terminus and intracellular loop 2
We hypothesized that ubiquitin-conjugation of mGlu7 occurs in the eight lysine residues in the C-terminal tail (CT) 1 of mGlu7 (Figure 2A) . To determine which lysine residues are responsible for ubiquitin-conjugation of mGlu7, we 2 generated sequential deletion mutants (mGlu7 893, 879, 860, and 857) by introducing a stop codon at the 3 position of designated amino acid numbers, and examined ubiquitination of these mutants. Unexpectedly, the level 4 of ubiquitination was not reduced in any deletion mutants including mGlu7 857, which does not possess any lysine 5 residues in its CT (Figure 2B) . We recognized four additional lysine residues present in the intracellular loop (iL) 2 6 and 3 domains (Figure 2A) , and thus generated iL mutants such that all four lysine residues in iLs were individually 7 replaced with arginine residues (mGlu7 iL 4K4R) by site-directed mutagenesis. Consistent with the data using 8 deletion mutants, the mGlu7 CT 8K8R mutant, in which all eight lysine residues in mGlu7 CT were mutated to 9 arginines, was as efficiently ubiquitinated as mGlu7 WT after treatment of L-Glu for 10 min (Figure 2C) . However, 10 the efficiency of ubiquitination of mGlu7 iL 4K4R was also similar to that of mGlu7 WT or CT 8K8R (Figure 2C) , 11
suggesting that the lysines on iLs are not the only ubiquitination sites. The ubiquitination of the mGlu7 12K12R 12 mutant in which all twelve lysine residues were mutated to arginines was almost completely abolished ( Figure 2C) . 13
Taken together, these results suggest that mGlu7 is ubiquitinated at lysine residues of both iLs and CT. 14 To further map the specific lysine residues to which ubiquitin is covalently attached on the iL domains of 15 mGlu7, lysine residues in the iL domains were mutated to arginines in combination with mGlu7 857 mutant. We 16
found that K688 and K689 mutations in the iL2 (iL K688/689R) with mGlu7 857 lead to the marked reduction of 17 mGlu7 ubiquitination to a similar level as iL 4K4R with mGlu7 857, suggesting the K688 and K689 residues are 18 ubiquitinated residues in the iL domains of mGlu7 ( Figure 2D ). However, in spite of further mutagenesis studies we 19
were not able to identify dominant ubiquitination sites among eight mGlu7 CT resides (data not shown), suggesting 20 that the two lysine residues K688 and K689 in iL2 and all eight lysine residues in CT are the target ubiquitination 21 residues of mGlu7. among -arrestins, Nedd4, and mGlu7. FLAG-mGlu7, -arrestin 1-or 2-GFP, and HA-Nedd4 were co-transfected in 1 HEK 293T cells and mGlu7 was immunoprecipitated by anti-FLAG antibody (Figures 3A and 3B) . We observed 2 that -arrestins and Nedd4 bind constitutively to mGlu7 before stimulation with agonist L-Glu ( Figure 3A) . Of 3 particular interest, agonist stimulation rapidly increased binding of -arrestin 1 to mGlu7 within 5 min by 4 approximately 1.8 fold relative to basal binding levels ( Figure 3C ). This interaction was sustained for 15 min and 5 decreased to basal levels after 30 min (Figures 3A and 3C) . Binding of Nedd4 to mGlu7 was also elevated after 5 6 min of agonist stimulation when -arrestin 1 was co-expressed ( Figures 3A and 3D) . After 60 min of agonist 7 treatment, binding of -arrestin 1 or Nedd4 to mGlu7 was reduced, probably due to the degradation of the receptor 8
( Figures 3A and 3C) . Binding of -arrestin 2 to mGlu7 exhibited a smaller degree of increase by 1.2 fold at 5 min 9
after agonist treatment (Figures 3B and 3C) . Nedd4 binding to mGlu7 was also increased at 5 min of agonist 10 stimulation when -arrestin 2 was co-expressed ( Figures 3B and 3D) . 11
Next, we examined the time course of binding between Nedd4 and -arrestin 1 when mGlu7 was activated. 12
We found that -arrestin 1 and Nedd4 are rapidly associated within 1 min and their interaction continued more than 13 10 min after mGlu7 agonist stimulation (Figures 3E and 3F ), suggesting that Nedd4 is recruited to the activated 14 mGlu7 by -arrestin 1. To confirm the role of -arrestins in the recruitment of Nedd4 to mGlu7, we knocked down 15 -arrestin 1 or 2 by co-transfection with -arrestin 1 or 2 shRNA in HEK 293T cells, respectively. We found that 16
both -arrestin 1 (β-arr1 KD) and 2 knockdown (β-arr2 KD) abolished an increase in agonist-induced binding of 17
Nedd4 to mGlu7 (Figures 3G and 3H) , indicating that agonist-induced recruitment of Nedd4 to mGlu7 is mediated 18 by -arrestins. 19
Our results indicate that -arrestins and Nedd4 form a complex with mGlu7 in the basal state, and upon 20 agonist stimulation -arrestins are further recruited to mGlu7, which promotes Nedd4 binding to mGlu7. Therefore 21
we tested whether -arrestins affect mGlu7 ubiquitination by recruiting Nedd4 in cultured hippocampal neurons. We 22 found that agonist-induced mGlu7 ubiquitination levels were significantly reduced by both -arrestin 1 and 2 KD, To determine the binding domains between Nedd4 and mGlu7, we performed GST pull-down assays using GST-30 fused mGlu7 CT or iL domains which were immobilized on Glutathione-Sepharose 4B beads. Specifically, GST-31 fused mGlu7 iL1, iL2, iL3, mGlu7a CT, or mGlu7b CT domains were incubated with lysates from the whole rat 32 brains and the binding proteins to each domain were isolated. mGlu7b is a splice variant of mGlu7a and has different 33 amino acid sequences only in its distal CT (Flor et al., 1997) . We found that both Nedd4 and -arrestin 1 bind to the Student's t-test).
7
The following figure supplement is available for figure 3: and -arrestin 2 proteins were harvested from an E. coli expression system and purified using Ni-NTA resin. We 15 performed in vitro binding assays and found that purified Nedd4 protein directly binds to mGlu7 CT and iL2 16
domains immobilized on Glutathione-Sepharose beads (Figure 4B ). Both -arrestin 1 and -arrestin 2 purified 17 proteins also directly interacted with mGlu7 CTs and iL2 ( Figure 4B) . 18
We next sought to identify the Nedd4 domain responsible for interaction with mGlu7. As Nedd4 contains 4 19 WW domains and a HECT domain, we generated FLAG-tagged deletion mutants of Nedd4 in which each domain 20 was deleted by site-directed fragment deletion mutagenesis ( Figure 4C) . We performed co-immunoprecipitation 21 assay with myc-mGlu7, and found that Nedd4 HECT mutant does not interact with mGlu7, indicating the Nedd4 22
HECT domain is responsible for interaction with mGlu7 ( Figure 4D) . 23 24 Nedd4 and -arrestins regulate mGlu7 surface expression and agonist-induced endocytosis 25 We previously reported that PTMs such as phosphorylation and SUMOylation regulate mGlu7 endocytosis in Nedd4-mediated ubiquitination on mGlu7 in receptor trafficking, we co-transfected myc-mGlu7 and Nedd4 WT or 28 C867S in cultured hippocampal neurons. We first labeled surface-expressed receptors with anti-myc antibody and 29 allowed endocytosis at 37 C for 15 min in the absence or presence of agonist L-AP4. Remaining receptors on the 30 cell surface were visualized with Alexa Fluor 568-conjugated secondary antibodies before permeabilization (red), 31
and internalized receptors were labeled with Alexa Fluor 488-conjugated secondary antibodies after 32 permeabilization (green). We observed a marked increase in mGlu7 endocytosis by Nedd4 WT, but not by Nedd4 33 C867S (Figures 5A, 5B-figure supplement 2A) . We also found that agonist-induced endocytosis of mGlu7 was 34 impaired by co-expression of Nedd4 shRNA (Nedd4 KD) compared with control shRNA (Ctl KD) in hippocampal It has been proposed that β-arrestins initiate β-arrestin-dependent signaling to ERK1/2, one of the MAPKs in the 20 plasma membrane and endosomes (Eichel et al., 2018; Nuber et al., 2016; Thomsen et al., 2016) . Although L-AP4-21
induced ERK activation has been reported to require β-arrestin 2 but not β-arrestin 1 in neurons (Gu et al., 2012; ERK1/2 phosphorylation significantly increased after 5 min treatment with L-AP4 in Ctl KD or β-arr1 KD neurons, 1 whereas β-arr2 KD or Nedd4 KD did not induce agonist-induced ERK1/2 phosphorylation (Figures 6A and 6B) , 2 indicating the necessity for β-arrestin 2 and Nedd4 in mGlu7-mediated ERK signaling. We observed a similar 3 impairment of agonist-induced c-Jun N-terminal kinases (JNKs) activation in β-arr2 KD neurons. Either β-arr1 KD 4 or Nedd4 KD has little effect on mGlu7-mediated JNK signaling (Figures 6A and 6C) . These results suggest that 5 mGlu7-dependent ERK signaling is regulated by β-arrestin 2 and depends on Nedd4-mediated ubiqutination, 6
whereas JNK signaling is independent of Nedd4-mediated ubiquitination in neurons. 7 8 Nedd4-mediated ubiquitination leads to degradation of mGlu7 by both the lysosomal and 9 proteasomal degradation pathways 10 During the experiments to analyze mGlu7 ubiquitination, we observed a marked decrease in total expression of 11 mGlu7 when agonist L-Glu was administered for more than 30 min or Nedd4 was co-transfected ( Figures 1B and  12   1E ). As is evident in figure 7A , total expression of mGlu7 was reduced when Nedd4 was co-expressed with mGlu7. 13
However, co-expression of Nedd4 C867S had little effect on total expression of mGlu7 (Figure 7A) . The total 14 expression level of mGlu7 was reduced by L-Glu treatment for 60 min, which was blocked by co-expression of 15
Nedd4 C867S (Figure 7B) . These results indicate that the surface stability of mGlu7 is determined by Nedd4-16 mediated ubiquitin modification of mGlu7. To further investigate the degradation pathway of ubiquitinated mGlu7, 17
we treated mGlu7-transfected HEK 293T cells with MG132 (proteasome inhibitor) or leupeptin (lysosome inhibitor) 18 for 2 h prior to treatment with L-Glu. We found that agonist-induced mGlu7 degradation was significantly blocked 19 by leupeptin treatment (Figures 7C and 7D) . This result indicates that ubiquitination regulates the intracellular 20 sorting of mGlu7 into early and late endosomes, and subsequent degradation in lysosomes. Furthermore, we were 21 able to observe that MG132 also inhibits agonist-induced mGlu7 degradation (Figures 7C and 7D) , implying that 22 ubiquitin-proteasome systems are also involved in the control of mGlu7 protein homeostasis. an activity-dependent manner. We found that mGlu7 undergoes constitutive and agonist-induced ubiquitination in 13 the lysine residues of both iL2 and CT, which is primarily mediated by Nedd4 E3 ligase. Upon agonist-stimulation, 14 -arrestins are able to recruit Nedd4 to mGlu7 and facilitate ubiquitination of mGlu7. Nedd4 and -arrestins regulate 15 constitutive and agonist-induced endocytosis of mGlu7, and are required for MAPK signaling of mGlu7 in neurons. 16
Finally, Nedd4-mediated mGlu7 ubiquitination regulates receptor stability through both the lysosomal and the 17 proteasomal degradation pathways. 18
The E3 ubiquitin ligase is a key determinant of substrate specificity by catalyzing the transfer of ubiquitin 19 from E2 enzymes to target proteins. Little is known about E3 ligases about their role in regulating the ubiquitination 20 of mGlu receptors. Siah-1A (seven in absentia homolog-1A) is the first identified E3 ubiquitin ligase for Group 1 21 mGlu receptors (Moriyoshi et al., 2004) . Siah-1A directly binds to Group 1 mGlu receptors and mediates receptor 22 ubiquitination, resulting in receptor degradation via the ubiquitin-proteasome pathway. Siah-1A also regulates 23
agonist-induced endocytosis of mGlu5 by displacing calmodulin binding, and promotes the lysosomal degradation 24 of mGlu5 (Gulia et al., 2017; Ishikawa et al., 1999; Ko et al., 2012) . In contrast, we have identified Nedd4 as a 25 primary E3 ligase for ubiquitination of mGlu7, a presynaptically expressed Group III mGlu receptor. Although mGlu7 does not possess the PPxY motif, a canonical Nedd4 binding motif, Nedd4 directly binds to mGlu7 by HECT 1 domain of Nedd4. Nedd4 alters ERK signaling and regulates mGlu7 trafficking by inducing ubiquitination which 2 results in the endocytosis and degradation of surface-expressed mGlu7 into proteasomes and lysosomes. We 3 observed a marked induction of mGlu7 ubiquitination when exogenous ubiquitin was co-expressed with mGlu7 in 4 HEK 293T cells. In contrast, endogenous mGlu7 ubiquitination induced by agonist stimulation was less prominent 5 in neurons (Figures 1C and 1F) . This result likely occurs because only the surface-expressed fraction of mGlu7 can 6 be ubiquitinated directly from agonist stimulation. We have observed that agonist stimulation increases 7 ubiquitination of the surface-expressed mGlu7 to some degree but not ubiquitination of the intracellular mGlu7 8 (Figure 1D) . We were not able to observe more prominent endogenous mGlu7 ubiquitination with longer agonist 9
incubations for up to 2 h or by other neuronal stimulation such as bicuculline or KCl (data not shown). 10
We identified two binding sites, iL2 and CT in mGlu7 that interact with -arrestins and Nedd4. Recently, a 11 crystal structure of rhodopsin-arrestin complex revealed that a conserved serine/threonine-rich domain, 12
Px(x)PxxP/E/D (P, phospho-serine or phospho-threonine; X, any amino acid) across the major GPCR subfamilies 13 serves as a common phosphorylation code for arrestin recruitment (Zhou et al., 2017) . A serine/threonine rich 14 domain on mGlu7 CT (868-TAATMSSRLS-877) is compatible with this phosphorylation code for arrestin binding, and 15
is therefore a candidate -arrestin-interacting domain. In addition, the iL2 domain of GPCRs has been shown to 16 contribute to association with -arrestin by providing a partial core contact site for both Gα and -arrestin (Hilger et  17   al., 2018; Latorraca et al., 2018; Ranjan et al., 2017) . It was shown that the iL2 domain of mGlu receptors 18 including mGlu8 determines G-protein coupling selectivity (Francesconi and Duvoisin, 1998; Gomeza et al., 1996;  19   Havlickova et al., 2003; Pin et al., 1994) . Furthermore, in addition to the CT domain, the iL2 domain of mGlu1 is a 20 site for GRK2 binding and GRK2-mediated signaling (Dhami et al., 2005) . Accordingly, additional binding of -21 arrestin-Nedd4 complex to mGlu7 iL2 may sterically hinder G-protein binding and provide a platform for a receptor 22 core for fully-engaged binding of -arrestin to mGlu7. 23
It has been expected that -arrestin 1 and -arrestin 2 are functionally redundant due to the high degree of 24 sequence and structural similarity, however recent studies have suggested their partially distinct functional roles 25 (Srivastava et al., 2015) . For example, the desensitization, ubiquitination, and endocytosis of 2AR is primarily 26 mediated by -arrestin 2, not by -arrestin 1 (Han et al., 2013; Jean-Charles et al., 2016; Shenoy and Lefkowitz,  27   2011 ). AT1aR-mediated ERK signaling is eliminated by -arr2 KD in HEK293 cells, while -arr1 KD augments 28 ERK signaling (Ahn et al., 2004; Srivastava et al., 2015) . Several studies have reported the controversial effects of 29 -arrestins in the endocytosis of Group I mGlu receptors (Iacovelli et al., 2013; Suh et al., 2018) . Constitutive (Dale et al., 2001) . 33
In contrast, -arrestin 1 does not seem to directly participate in agonist-induced mGlu1 endocytosis (Iacovelli et al., with mGlu7 and are recruited to mGlu7 by agonist stimulation. Both -arrestin 1 and 2 are required for constitutive 1 endocytosis of mGlu7 in cultured hippocampal neurons. In addition, our study has demonstrated that -arrestin 2 2 rather than -arrestin 1 is involved in mGlu7-mediated ERK and JNK signaling in hippocampal neurons (Figure 6) . 3
In particular, Nedd4-mediated ubiquitination may be involved in ERK signaling rather than JNK signaling. In 4 contrast, Iacovelli et al. has reported the opposite effect of -arrestin 1 versus -arrestin 2 on mGlu7-mediated 5 signaling in HEK 293 cells. They showed that -arrestin 1 increases or decreases agonist-induced ERK or JNK 6 signaling, respectively, while -arrestin 2 exerts the opposite effects (Iacovelli et al., 2014) . This discrepancy may 7 be caused by the difference in the expression system of primary neurons versus heterologous cell lines. 8
Ubiquitin modification is involved in the endocytosis, recycling, and degradation of transmembrane proteins. 9
Upon ubiquitination, ligand-stimulated receptors on the plasma membrane are primarily degraded by the lysosome, 10
whereas most of the ubiquitinated proteins in the cytoplasm are degraded by the proteasome (Foot et al., 2017) . Our 11 present study showed that ligand-induced surface mGlu7 degradation is regulated by the ubiquitin-proteasome 12 pathway as well as the lysosomal degradation pathway (Figure 7) . It may be possible that ubiquitinated mGlu7 can 13 be directly translocated to the proteasome or ubiquitinated -arrestin-Nedd4 can guide mGlu7 as a complex to the 14 proteasome for degradation. Similar to our results, it has been reported that proteasomal activity is required for 15 ligand-induced degradation of the interleukin-2 receptor, platelet-derived growth factor  receptor, Met tyrosine 16 kinase receptor, epidermal growth factor receptor, growth hormone receptor, tropomyosin-regulated kinase A (TrkA) 17 receptor, and AMPA receptor (Geetha and Wooten, 2008; Jeffers et al., 1997; Kesarwala et al., 2009; Lin et al.,  18   2011; Lin and Man, 2013; Mori et al., 1995; van Kerkhof et al., 2000; Yu and Malek, 2001) . 19 In conclusion, -arrestins and Nedd4 play pivotal roles in regulating mGlu7 ubiquitination, endocytosis, 20 signaling, and stability in heterologous cells and neurons. These findings will offer novel mechanistic insights for 21 developing selective drugs with therapeutic potentials for mGlu7-related neuro-psychiatric disorders. 22
23
Materials and methods 24 
DNA constructs and antibodies 25
The plasmid encoding c-myc epitope-tagged mGlu7 in the N-terminus was described previously (Suh et al., 2013;  26   Suh et al., 2008) . FLAG-mGlu7 was generated by a site-directed fragment insertion protocol as previously 27 described (Park et al., 2016; Qi and Scholthof, 2008) . To insert FLAG sequence in the N-terminus, the 28 oligonucleotides that contain partially complementary FLAG sequences (upper case letters) at the 5ʹ end and mGlu7 29 sequences (lower case letters) at the 3ʹ end were generated as follows: forward, 5ʹ-TACAAAGACGATGACGACA-30
AGacgcgtatgtacgcc-3ʹ; reverse, 5ʹ-GTCGTCATCGTCTTTGTAGTCtcgcgtggactgtgc-3ʹ. The PCR reaction was 31 performed using Phusion DNA polymerase (Thermo Fisher Scientific) according to the manufacturer's 32 recommendations. HA-Ubiquitin (#17608), HA-Ubiquitin K48 (#17605), HA-Ubiquitin K63 (#17606), HA-Nedd4
The antibodies used in this study were purchased from the following commercial sources: anti-mGlu7a (#07-1 239, EMD Millipore), anti-c-myc (9E10, Sigma Aldrich), anti-HA (16B12, Covance), anti-FLAG (Sigma Aldrich), 2 anti-Ub (FK2, EMD Millipore; P4D1, Santa Cruz Biotechnology), anti-Nedd4 (#07-049, EMD Millipore; 3 MAB6218, R&D Systems), anti--arrestin 1 (Abcam), anti--arrestin 2 (Cell Signaling Technology). Alexa Fluor 4 488 or 568-conjugated goat anti-mouse IgG, and horseradish peroxidase-conjugated goat anti-mouse or rabbit IgG 5 were purchased from Thermo Fisher Scientific. removed by centrifugation at 20,000  g for 15 min at 4 °C. The supernatants were mixed with 6 X Laemmli sample 24 buffer, boiled at 95 °C for 5 min or incubated at 37 °C for 20 min and subsequently at 80 °C for 3 min. The samples 25
were resolved with SDS-PAGE, and transferred to PVDF membranes. The membranes were blocked with 5 % non-26 fat skim milk in 1 X TBST (0.1 % Tween 20) for 1 h at room temperature and then incubated with primary antibodies 27 overnight at 4 °C. Following several washings, the membranes were incubated with HRP-conjugated secondary 28
antibodies. The immunoreactive bands were detected with SuperSignal West Pico Chemiluminescent Substrate 29 (Thermo Fisher Scientific). For immunoprecipitation experiments, the lysates were pre-cleared with Sepharose 4B 30 beads for 1 h at 4°C. The pre-cleared supernatants were incubated with protein A-or G-Sepharose 4B beads (Sigma 31 Aldrich or Amersham) and with primary antibodies for 2-4 h at 4 °C. The immunoprecipitates were then washed four 32 times with lysis buffer and subjected to western blot analysis. 33
For the surface biotinylation assay, HEK 293T cells or neurons were incubated with 0.5 mg/ml EZ-Link biotinylated samples were lysed and supernatant was then incubated with 20 µl of Neutravidin or Streptavidin 1 agarose beads (Pierce) for 2 h at 4 °C. After washing the beads four times with lysis buffer, the bound proteins were 2 analyzed by western blotting. 3 4 Receptor internalization assay 5 The receptor internalization assay was performed as described elsewhere (Choi et al., 2016) . Briefly, transfected 6 neurons were incubated with 2 g/ml anti-c-myc antibody for 10 min at room temperature to label surface-expressed 7 receptors. The neurons were returned to the conditioned media containing 400 M L-AP4 or vehicle at 37 °C for 15 8 min to allow for the internalization of receptor-antibody complex. The neurons were fixed with 4 % 9 paraformaldehyde/4 % sucrose in 1 X PBS for 20 min and blocked with 10 % normal goat serum (NGS) for 1 h. Nedd4 (5ʹ-GCCACAAATCAAGAGTTAA-3ʹ) (Schwarz et al., 2010) , rat -arrestin 1 (5ʹ-AGCCTTCTGTGCTGA-21 GAAC-3ʹ) (Simard et al., 2013) , human -arrestin 1 (5ʹ-AAAGCCTTCTGCGCGGAGAAT-3ʹ) (Shenoy et al.,  22   2008 ), rat -arrestin 2 (5ʹ-GGACCGGAAAGTGTTTGTG-3ʹ) (Molteni et al., 2009) , human -arrestin 2 (5ʹ-GGCT-23 TGTCCTTCCGCAAAG-3ʹ) (Skanland et al., 2009) , control non-related target knockdown (5ʹ-AGTGGATTCGAG-24 AGCGTGT-3ʹ) (GenScript). To produce lentiviral particles, HEK 293T cells were co-transfected with lentiviral 25 vector, Δ 8.9, and VSVG vectors using X-tremeGENE (Roche). The medium was replaced by Neurobasal medium 26
supplemented with 1 % L-glutamine and Insulin-transferrin-sodium selenite (Sigma Aldrich). Supernatants 27 containing the viral particles were collected 60 h after transfection. 
